Covaxin Phase 3 Trial Data In July; 100% Effective Against Hospitalisations; Phase 4 Next
Photo courtesy: Republicworld
Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial, will publish the data in July, and following that the company will be applying for the full licensure for Covaxin. Speaking about Covaxin’s efficacy, Bharat Biotech said that the efficacy data of the vaccine have been reported at overall efficacy of 78 percent and efficacy against hospitalisations at 100 percent.
.
.
- 10 Jun 2021
- WerIndia
Loading ...
